首页> 外国专利> EYE GEL DROPS FOR TREATING ACUTE AND CHRONIC INFLAMMATORY EYE DISEASES CAUSED BY VIRAL, BACTERIAL, ALLERGIC, METABOLIC OR TRAUMATIC FACTORS

EYE GEL DROPS FOR TREATING ACUTE AND CHRONIC INFLAMMATORY EYE DISEASES CAUSED BY VIRAL, BACTERIAL, ALLERGIC, METABOLIC OR TRAUMATIC FACTORS

机译：治疗病毒性，细菌性，过敏性，代谢性或创伤性因素引起的急性和慢性炎症性眼病的眼药水

页面导航

摘要
著录项
相似文献

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, namely to ophthalmology, and aims at treating acute and chronic inflammatory eye diseases caused by viral, bacterial, allergic, metabolic or traumatic factors. Eye gel-like drops contain human recombinant interferon specified in the group: alpha-, beta-, gamma-interferon or their mixture; boric acid; phosphate buffer; sodium hyaluronate; taurine; cyanocobalamin or hydroxoxobalamin; dexpanthenol; an antihistamine preparation selected from: olopatidine, azelastine or levocabastine; and water. Components are used in claimed amounts.;EFFECT: use of the invention allows improving the treating properties of physiologically active substances without the need to increase their concentration with simultaneous reduction of the probability of undesirable side effects.;1 cl, 1 tbl, 17 ex

机译：技术领域本发明涉及医学，即眼科，旨在治疗由病毒，细菌，过敏，代谢或创伤性因素引起的急性和慢性炎症性眼病。眼凝胶状滴剂含有以下类别的人重组干扰素：α-，β-，γ-干扰素或其混合物;硼酸磷酸盐缓冲液;透明质酸钠;牛磺酸氰钴胺素或羟氧羰基巴胺;右泛醇一种抗组胺制剂，选自：olopatidine，氮卓斯汀或左卡巴汀;和水。组分以要求的量使用。效果：本发明的使用允许改善生理活性物质的治疗特性，而无需增加其浓度，同时降低了不良副作用的可能性。1 cl，1 tbl，17 ex

著录项

公开/公告号RU2692087C1

专利类型
公开/公告日2019-06-21

原文格式PDF
申请/专利权人 MARKOV ILYA ALEKSANDROVICH;
展开▼

申请/专利号RU20180141576
发明设计人 MARKOV ILYA ALEKSANDROVICH (RU);MAJCHUK YURIJ FEDOROVICH (RU);MAJCHUK DMITRIJ YUREVICH (RU);MARKOVA ELENA ALEKSEEVNA (RU);GAPONYUK POLINA PETROVNA (RU);MARKOVA INNA NIKOLAEVNA (RU);GAPONYUK PETR YAKOVLEVICH (RU);
展开▼

申请日2018-11-27
分类号A61K31/185;A61K31/197;A61K31/714;A61K31/728;A61K33/22;A61K38/21;A61P27/02;
国家 RU
入库时间 2022-08-21 11:46:10

相似文献

专利
外文文献
中文文献